{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "exchange": "PNK", "shortName": "ALGERNON PHARMACEUTICALS INC", "longName": "Algernon Pharmaceuticals Inc.", "messageBoardId": "finmb_327047624", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.120363, "regularMarketPrice": 0.1829, "marketState": "REGULAR", "regularMarketChange": -0.007860005, "regularMarketTime": 1684251410, "regularMarketDayHigh": 0.19195, "regularMarketDayRange": "0.1829 - 0.19195", "regularMarketDayLow": 0.1829, "regularMarketVolume": 856, "regularMarketPreviousClose": 0.19076, "fullExchangeName": "Other OTC", "financialCurrency": "CAD", "regularMarketOpen": 0.19195, "averageDailyVolume3Month": 14062, "averageDailyVolume10Day": 3783, "fiftyTwoWeekLowChange": 0.012899995, "fiftyTwoWeekLowChangePercent": 0.07588232, "fiftyTwoWeekRange": "0.17 - 1.325", "fiftyTwoWeekHighChange": -1.1421001, "fiftyTwoWeekHighChangePercent": -0.8619623, "fiftyTwoWeekLow": 0.17, "fiftyTwoWeekHigh": 1.325, "dividendDate": 1539734400, "earningsTimestamp": 1651089600, "earningsTimestampStart": 1651089600, "earningsTimestampEnd": 1651089600, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.52, "sharesOutstanding": 11532000, "bookValue": 0.596, "fiftyDayAverage": 0.2550104, "fiftyDayAverageChange": -0.0721104, "fiftyDayAverageChangePercent": -0.28277436, "twoHundredDayAverage": 0.51184577, "twoHundredDayAverageChange": -0.32894576, "twoHundredDayAverageChangePercent": -0.64266574, "marketCap": 2160542, "priceToBook": 0.3068792, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "firstTradeDateMilliseconds": 1457706600000, "priceHint": 4, "tradeable": false, "cryptoTradeable": false, "displayName": "Algernon Pharmaceuticals", "symbol": "AGNPF"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "601 West Broadway", "address2": "Suite 400", "city": "Vancouver", "state": "BC", "zip": "V5Z 4C2", "country": "Canada", "website": "https://algernonpharmaceuticals.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of non\u0096alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada, Australia, and New Zealand. The company's pipeline includes Ifenprodil, which completed Phase 2 clinical trial for the treatment of idiopathic pulmonary fibrosis and chronic cough; repirinast, which is in preclinical stage for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine, which has completed preclinical stage for the treatment of strokes. The company was formerly known as \u0093Breathtec Biomedical, Inc. and changed its name to Algernon Pharmaceuticals Inc. in July 2015. Algernon Pharmaceuticals Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Christopher J. Moreau", "age": 57, "title": "CEO & Director", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": {"raw": 421966, "fmt": "421.97k", "longFmt": "421,966"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. James F. Kinley C.A., CPA", "age": 44, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2022, "totalPay": {"raw": 124471, "fmt": "124.47k", "longFmt": "124,471"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Christopher  Bryan Ph.D.", "age": 39, "title": "VP of Research & Operations", "yearBorn": 1983, "fiscalYear": 2022, "totalPay": {"raw": 188522, "fmt": "188.52k", "longFmt": "188,522"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}